RKDA
Arcadia Biosciences, Inc.Substantial doubt about the company's ability to continue as a going concern.
“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company's ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-05-09 | Kawakami Mark |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
12,500 |
| 2025-05-09 | Schaefer Thomas J. |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
12,500 |
| 2025-02-03 | Schaefer Thomas J. |
Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2021 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower. |
Common Stock
|
700 |
| 2025-02-03 | Kawakami Mark |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from August 1, 2022 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower. |
Common Stock
|
700 |
| 2024-08-19 | Schaefer Thomas J. |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
20,000 |
| 2024-08-19 | Murray Lilian Shackelford |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
10,909 |
| 2024-08-19 | Kawakami Mark |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
20,000 |
| 2024-08-19 | Yoder Amy |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
10,909 |
| 2024-08-19 | Carosella Deborah D |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
10,909 |
| 2024-08-19 | Bolles Albert D. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
10,909 |
| 2024-08-19 | Comcowich Kevin |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
25,455 |
| 2024-08-19 | WALLER GREGORY D |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
10,909 |
| 2024-08-01 | Kawakami Mark |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2022 to August 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase. |
Common Stock
|
700 |
| 2024-08-01 | Schaefer Thomas J. |
Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2021 to August 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase. |
Common Stock
|
700 |
| 2024-02-01 | Schaefer Thomas J. |
Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 700 shares of the Issuer's common stock on 2/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2021 to February 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase. |
Common Stock
|
700 |
| 2023-08-04 | Schaefer Thomas J. |
Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 649 shares of the Issuer's common stock on 8/1/23 at a per share purchase price of $3.67 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2021 to August 1, 2023. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase. |
Common Stock
|
649 |
| 2023-06-06 | Murray Lilian Shackelford |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
937 |
| 2023-06-06 | Comcowich Kevin |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
2,186 |
| 2023-06-06 | Carosella Deborah D |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
937 |
| 2023-06-06 | Yoder Amy |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
937 |
| 2023-06-06 | Bolles Albert D. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
937 |
| 2023-06-06 | WALLER GREGORY D |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (Right to Buy)
|
937 |
| 2023-05-30 | Jacot Stanley Jr |
Chief Executive Officer |
Buy↑
Filing footnotes — Common stock (Direct)
This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Common stock
|
5,000 |
| 2023-04-04 | PITLIK LAURA |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-04-04 | Schaefer Thomas J. |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-04-04 | Jacot Stanley Jr |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-02-01 | Schaefer Thomas J. |
Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 700 shares of the Issuer's common stock on 2/1/23 at a per share purchase price of $0.23 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from February 1, 2021 to February 1, 2023. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase. |
Common Stock
|
700 |
| 2023-01-03 | Schaefer Thomas J. |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options were granted on 1/3/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs. |
Stock Option (Right to Buy)
|
50,000 |
| 2022-08-16 | PITLIK LAURA |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option vests in two equal installments occurring on the first, and second anniversary of the date of grant. |
Stock Option (right to buy)
|
23,000 |
| 2022-08-16 | Haley Pamela |
Interim CFO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option vests in two equal installments occurring on the first, and second anniversary of the date of grant. |
Stock Option (right to buy)
|
23,000 |
| 2022-08-01 | Haley Pamela |
Interim CFO |
Buy↑
Filing footnotes — Common Stock (Direct)
Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/22 at a per share purchase price of $0.70 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase period of August 4, 2020 to August 1, 2022. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase. |
Common Stock
|
700 |
| 2022-06-01 | Comcowich Kevin |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
55,114 |
| 2022-06-01 | Murray Lilian Shackelford |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
23,620 |
| 2022-06-01 | Yoder Amy |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
23,620 |
| 2022-06-01 | Bolles Albert D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
23,620 |
| 2022-06-01 | WALLER GREGORY D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
23,620 |
| 2022-06-01 | Carosella Deborah D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
23,620 |
| 2022-04-11 | PITLIK LAURA |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option vests in two equal installments occurring on the first, and second anniversary of the date of grant, subject to the Participant's continued service. |
Stock Option (right to buy)
|
23,000 |
| 2022-04-11 | PITLIK LAURA |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service. |
Stock Option (right to buy)
|
31,000 |
| 2022-04-11 | Haley Pamela |
Interim CFO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The option vests in two equal installments occurring on the first, and second anniversary of the date of grant. |
Stock Option (right to buy)
|
38,000 |
| 2022-04-11 | Haley Pamela |
Interim CFO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service. |
Stock Option (right to buy)
|
50,000 |
| 2022-02-02 | Jacot Stanley Jr |
Chief Executive Officer |
Other↑
|
No Securities Owned
|
0 |
| 2022-02-02 | Jacot Stanley Jr |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service. |
Stock Option (right to buy)
|
316,108 |
| 2021-07-12 | PITLIK LAURA |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service. |
Stock Option (right to buy)
|
75,000 |
| 2021-07-12 | PITLIK LAURA |
Chief Marketing Officer |
Other↑
|
No Securities Owned
|
0 |
| 2021-06-02 | Comcowich Kevin |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
25,514 |
| 2021-06-02 | Bolles Albert D. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
10,935 |
| 2021-06-02 | Yoder Amy |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
10,935 |
| 2021-06-02 | Murray Lilian Shackelford |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
10,935 |
| 2021-06-02 | WALLER GREGORY D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Stock Option (right to buy)
|
10,935 |